- Home
- DVA vs DT Comparison
DVA vs DT Comparison
Compare DVA & DT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVA
- DT
- Stock Information
- Founded
- DVA 1994
- DT 2005
- Country
- DVA United States
- DT United States
- Employees
- DVA N/A
- DT N/A
- Industry
- DVA Misc Health and Biotechnology Services
- DT Computer Software: Prepackaged Software
- Sector
- DVA Health Care
- DT Technology
- Exchange
- DVA Nasdaq
- DT Nasdaq
- Market Cap
- DVA 10.9B
- DT 13.0B
- IPO Year
- DVA 1995
- DT 2019
- Fundamental
- Price
- DVA $136.18
- DT $54.00
- Analyst Decision
- DVA Hold
- DT Buy
- Analyst Count
- DVA 4
- DT 25
- Target Price
- DVA $157.00
- DT $60.13
- AVG Volume (30 Days)
- DVA 828.5K
- DT 3.0M
- Earning Date
- DVA 05-12-2025
- DT 05-14-2025
- Dividend Yield
- DVA N/A
- DT N/A
- EPS Growth
- DVA 14.90
- DT 205.77
- EPS
- DVA 10.11
- DT 1.59
- Revenue
- DVA $12,968,524,000.00
- DT $1,698,683,000.00
- Revenue This Year
- DVA $6.00
- DT $18.62
- Revenue Next Year
- DVA $3.66
- DT $14.74
- P/E Ratio
- DVA $13.48
- DT $33.97
- Revenue Growth
- DVA 5.11
- DT 18.75
- 52 Week Low
- DVA $131.76
- DT $39.30
- 52 Week High
- DVA $179.60
- DT $63.00
- Technical
- Relative Strength Index (RSI)
- DVA 37.73
- DT 67.49
- Support Level
- DVA $136.50
- DT $53.06
- Resistance Level
- DVA $140.42
- DT $54.66
- Average True Range (ATR)
- DVA 3.66
- DT 1.12
- MACD
- DVA -0.59
- DT 0.10
- Stochastic Oscillator
- DVA 11.71
- DT 86.59
About DVA DaVita Inc.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.
About DT Dynatrace Inc.
Dynatrace is a cloud-native company that focuses on analyzing machine data. Its product portfolio, delivered as software as a service, allows a client to monitor and analyze its entire IT infrastructure. Dynatrace's platform can ingest and analyze large amounts of machine-generated data in real time, allowing clients to use it for a variety of applications throughout their businesses.